288 related articles for article (PubMed ID: 34721714)
21. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
[TBL] [Abstract][Full Text] [Related]
22. Practical assessment of myocardial viability with a positron coincidence gamma camera using 18F-fluorodeoxyglucose in acute myocardial infarction: comparison with dedicated positron emission tomography and 201Tl single photon emission computed tomography.
Seki R; Seki H; Toyama T; Koyama K; Endo K; Kurabayashi M
J Cardiol; 2009 Apr; 53(2):265-71. PubMed ID: 19304132
[TBL] [Abstract][Full Text] [Related]
23. Neuronuclear assessment of patients with epilepsy.
Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W
Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079
[TBL] [Abstract][Full Text] [Related]
24. Nuclear medicine practice in Japan: a report of the seventh nationwide survey in 2012.
Kinuya S; Kuwabara Y; Inoue K; Sakamoto S; Shimosegawa E; Takeoka K; Takeda Y; Toyama H; Niio Y; Nishiyama Y; Yoshinaga K; Yoshimura M
Ann Nucl Med; 2014 Dec; 28(10):1032-8. PubMed ID: 25113149
[TBL] [Abstract][Full Text] [Related]
25. [Established nuclear medicine techniques for tumour diagnosis (tumour SPECT): can they still compete with (18)F-FDG-PET?].
Schmidt M; Eschner W; Dietlein M; Theissen P; Schicha H
Nuklearmedizin; 2005 Feb; 44(1):37-48; quiz N2-3. PubMed ID: 15711728
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous in vivo imaging with PET and SPECT tracers using a Compton-PET hybrid camera.
Uenomachi M; Takahashi M; Shimazoe K; Takahashi H; Kamada K; Orita T; Ogane K; Tsuji AB
Sci Rep; 2021 Sep; 11(1):17933. PubMed ID: 34504184
[TBL] [Abstract][Full Text] [Related]
27. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
28. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
[TBL] [Abstract][Full Text] [Related]
29. Combined imaging modalities: PET/CT and SPECT/CT.
Maurer AH
Health Phys; 2008 Nov; 95(5):571-6. PubMed ID: 18849691
[TBL] [Abstract][Full Text] [Related]
30. The role of hybrid cameras in oncology.
Delbeke D; Sandler MP
Semin Nucl Med; 2000 Oct; 30(4):268-80. PubMed ID: 11105928
[TBL] [Abstract][Full Text] [Related]
31. [THE HISTORY OF NUCLEAR MEDICINE IN ISRAEL: FROM OCCULT MEDICINE TO AN ADVANCED MULTIDISCIPLINARY SPECIALTY].
Zwas T
Harefuah; 2021 Jul; 160(7):468-473. PubMed ID: 34263576
[TBL] [Abstract][Full Text] [Related]
32. [Indications and instructions to patients for a positron emission tomography-PET scan. The importance of the hybridic PET/CT-computerised tomography scan and which specialty should be responsible for its function].
Grammaticos P; Datseris I; Gerali S; Papantoniou V; Valsamaki P; Boundas D
Hell J Nucl Med; 2007; 10(2):125-8. PubMed ID: 17684593
[TBL] [Abstract][Full Text] [Related]
33. Positron emission tomography imaging in oncology.
Delbeke D; Martin WH
Radiol Clin North Am; 2001 Sep; 39(5):883-917. PubMed ID: 11587060
[TBL] [Abstract][Full Text] [Related]
34. A comparison of 18F-FDG gamma camera PET, mammography and ultrasonography in demonstrating primary disease in locally advanced breast cancer.
Marshall C; Mustafa S; Wheatley DC; Eremin JE; El-Sheemy M; Jibril JA; Eremin O; Griffiths PA
Nucl Med Commun; 2004 Jul; 25(7):721-5. PubMed ID: 15208500
[TBL] [Abstract][Full Text] [Related]
35. Equivalent Dose Rate 1 Meter from Neuroendocrine Tumor Patients Exiting the Nuclear Medicine Department After Undergoing Imaging.
Zhang-Yin J; Dirand AS; Sasanelli M; Corrégé G; Peudon A; Kiffel T; Nataf V; Clerc J; Montravers F; Talbot JN
J Nucl Med; 2017 Aug; 58(8):1230-1235. PubMed ID: 28209907
[No Abstract] [Full Text] [Related]
36. Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom.
Sunderland JJ; Christian PE
J Nucl Med; 2015 Jan; 56(1):145-52. PubMed ID: 25525180
[TBL] [Abstract][Full Text] [Related]
37. Designing a New Molecular Probe: The Potential Role for Tilmanocept (Lymphoseek
Adesanya OO; Hutchinson CE
Open Orthop J; 2017; 11():212-224. PubMed ID: 28458734
[TBL] [Abstract][Full Text] [Related]
38. Review: comparison of PET rubidium-82 with conventional SPECT myocardial perfusion imaging.
Ghotbi AA; Kjaer A; Hasbak P
Clin Physiol Funct Imaging; 2014 May; 34(3):163-70. PubMed ID: 24028171
[TBL] [Abstract][Full Text] [Related]
39. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.
Halley A; Hugentobler A; Icard P; Porret E; Sobrio F; Lerochais JP; Bouvard G; Zalcman G; Agostini D
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1026-32. PubMed ID: 15877227
[TBL] [Abstract][Full Text] [Related]
40. PET versus SPECT for determining myocardial tissue viability using fluorine-18-fluorodeoxyglucose.
Schraml FV; Driver DR; Randolph T; Silverman ED
J Nucl Med Technol; 1997 Dec; 25(4):272-4. PubMed ID: 9438929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
